© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
July 13, 2020
“One FDA approval that we were quite excited about (is Tabrecta). And I've actually already put some patients on it; it's a very good drug,” Dr. Timothy Burns said in a recent interview.
An Angel Among Nurses for Patients With Lung Cancer
Cancer’s Hidden Threat: Post-Diagnosis Anxiety
Expansion of IOA-244 Trial Fully Enrolled for Uveal Melanoma
Phenomenal Awareness and Community Perspective for Lung Cancer Screenings